Overview

Vigabatrin for Cocaine and Alcohol Dependence

Status:
Terminated

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effectiveness of vigabatrin at reducing drug and alcohol use in individuals addicted to cocaine and alcohol. Vigabatrin is approved for the treatment of seizures. It has not been proven to be effective for the treatment of alcohol or cocaine dependence.

Phase:

Phase 2

Details

Lead Sponsor:

University of Pennsylvania

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Cocaine
Vigabatrin